Clinical Research Directory

Feasibility of Semaglutide in Advanced Lung Disease

Sponsor: University of Pennsylvania

Summary

The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung disease. The main question\[s\] it aims to answer are: 1. Are patients with advanced lung disease able to tolerate semaglutide therapy? 2. Are we able to titrate semaglutide therapy to a target weight? Participants will be asked to perform pulmonary function, physical function and body composition testing, as well as a blood draw before and after 12-weeks of semaglutide therapy. While on therapy, subjects will be surveyed regarding any adverse events or side effects.

Official title: Feasibility of Semaglutide Therapy for Weight Loss in Advanced Lung Disease: A Pilot Study

Key Details

Conditions

Interventions

Locations (1)